Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Lyudmila A. Ruyatkina"'
Publikováno v:
Ожирение и метаболизм, Vol 17, Iss 1, Pp 41-47 (2020)
The high prevalence of metabolic syndrome (MS) and subclinical hypothyroidism (SHypo) creates danger of integral cardio-metabolic risk (CMR). A concept is being developed to increase thyroid-stimulating hormone (TSH) levels as a component of MS with
Externí odkaz:
https://doaj.org/article/594bf30ae4a3425fbe3af2163f24b3d8
Autor:
Ivan I. Dedov, Marina V. Shestakova, Alexander Y. Mayorov, Minara S. Shamkhalova, Olga Yu. Sukhareva, Gagik R. Galstyan, Alla Y. Tokmakova, Tatiana V. Nikonova, Elena V. Surkova, Irina V. Kononenko, Daria N. Egorova, Lyudmila I. Ibragimova, Ekaterina A. Shestakova, Inna I. Klefortova, Igor A. Sklyanik, Ivona Ya. Yarek-Martynova, Anastasia S. Severina, Sergey A. Martynov, Olga K. Vikulova, Viktor Y. Kalashnikov, Irina Z. Bondarenko, Irina S. Gomova, Elena G. Starostina, Alexander S. Ametov, Mikhail B. Antsiferov, Tatiana P. Bardymova, Irina A. Bondar, Farida V. Valeeva, Tatiana Y. Demidova, Ashot M. Mkrtumyan, Nina A. Petunina, Lyudmila A. Ruyatkina, Lyudmila A. Suplotova, Olga V. Ushakova, Yurii Sh. Khalimov
Publikováno v:
Сахарный диабет, Vol 23, Iss 2S, Pp 4-102 (2020)
Public organization “Russian Association of Endocrinologists”. Clinical guidelines.
Externí odkaz:
https://doaj.org/article/294c9e40a2044186a97a78a328cbab76
Autor:
Ivan I. Dedov, Marina V. Shestakova, Alexander Y. Mayorov, Minara S. Shamkhalova, Tatiana V. Nikonova, Olga Y. Sukhareva, Elena V. Pekareva, Lyudmila I. Ibragimova, Margarita S. Mikhina, Gagik R. Galstyan, Alla Y. Tokmakova, Elena V. Surkova, Dmitry N. Laptev, Irina V. Kononenko, Daria N. Egorova, Inna I. Klefortova, Igor A. Sklyanik, Ivona Ya. Yarek-Martynova, Anastasia S. Severina, Sergey A. Martynov, Olga K. Vikulova, Viktor Y. Kalashnikov, Irina S. Gomova, Dmitry V. Lipatov, Elena G. Starostina, Alexander S. Ametov, Mikhail B. Antsiferov, Tatiana P. Bardymova, Irina A. Bondar, Farida V. Valeeva, Tatiana Y. Demidova, Vadim V. Klimontov, Ashot M. Mkrtumyan, Nina A. Petunina, Lyudmila A. Suplotova, Olga V. Ushakova, Yurii Sh. Khalimov, Lyudmila A. Ruyatkina
Publikováno v:
Сахарный диабет, Vol 23, Iss 1S, Pp 42-114 (2020)
Public organization “Russian Association of Endocrinologists”. Clinical guidlines.
Externí odkaz:
https://doaj.org/article/ea1852a3176049e3be057b302d59ae6f
Autor:
Marina V. Shestakova, Lyudmila A. Ruyatkina, Lyudmila A. Suplotova, Svetlana A. Smetanina, Elena B. Khramova, Natalia Y. Arbatskaya, Liudmila I. Ibragimova, Irina S. Iskhakova, Zukhra S. Pavlova, Alla V. Shilina, Fatima H. Dzgoeva, Minara S. Shamkhalova
Publikováno v:
Ожирение и метаболизм, Vol 16, Iss 1, Pp 82-93 (2019)
The scientific-practical conference Dietoogy In Practice Of Endocrinologist was held during the VIII Russian diabetology congress with international participation “Diabetes Mellitus – XXIth Century Pandemia”. It was chaired by Academician of RA
Externí odkaz:
https://doaj.org/article/3b140e01b3544c229c02cd5f33b2c09f
Publikováno v:
Ожирение и метаболизм, Vol 16, Iss 1, Pp 27-33 (2019)
The high prevalence of type 2 diabetes mellitus (T2DM) and atherosclerotic cardiovascular diseases (CVD) determines the need for early detection and correction of key markers of cardio-metabolic risk (CMR). This prophylactic direction is closely rela
Externí odkaz:
https://doaj.org/article/c75a21106e11490a9835d1e9888fe814
Autor:
Elena S. Mazurenko, Lyudmila A. Ruyatkina, Igor A. Pakhomov, Elena V. Chesheva, Larisa O. Gavrilova
Publikováno v:
Сахарный диабет, Vol 22, Iss 2, Pp 141-150 (2019)
BACKGROUND: Diabetic distal polyneuropathy (DDPN) is a predictor of diabetic foot syndrome development, ulcer formation and lower limb amputation. An early DDPN diagnosis is therefore relevant. AIM: To investigate the effectiveness and suitability of
Externí odkaz:
https://doaj.org/article/f9d71bd9da154f2fb6520711d8b3e0c7
Publikováno v:
Клиническая и экспериментальная тиреоидология, Vol 14, Iss 1, Pp 39-46 (2018)
Thyroid hormone resistance syndrome (RTH) is a rare disorder characterized by reduced peripheral tissue responses to thyroid hormones (TH) and elevated levels of circulating free thyroid hormones. Resistance to thyroid hormone is caused by mutations
Externí odkaz:
https://doaj.org/article/1ce1dd1d52814e09a4d68e40c4a65126
Publikováno v:
Сахарный диабет, Vol 20, Iss 3, Pp 210-219 (2017)
In modern algorithms for the treatment of type 2 diabetes, metformin is positioned as a first-line drug, which, when the disease progresses, is universally combined with other groups of hypoglycemic drugs, including insulin. Review of literature demo
Externí odkaz:
https://doaj.org/article/42c44c268da24bf5b6a47d750c9d373d
Publikováno v:
Сахарный диабет, Vol 19, Iss 2, Pp 171-178 (2016)
In recent years there is notable growing prevalence of gestational and overt diabetes in pregnant women while rate of obstetric complications, neonatal morbidity, perinatal mortality in women with diabetes is maintained at the high level as compared
Externí odkaz:
https://doaj.org/article/57a08367b1984eb0ad169b8f3b5b3762
Autor:
Lyudmila A. Ruyatkina, Marina Vladimirovna Shestakova, L. A. Suplotova, Gagik Radikovich Galstyan, M Sh Shamkhalova
Publikováno v:
Сахарный диабет, Vol 24, Iss 3, Pp 273-281 (2021)
Oral semaglutide is the first-in-class glucagon-like peptide-1 receptor agonist available in the form of pills administered per os. PIONEER — the clinical trial program assessing the efficacy and safety of oral semaglutide — demonstrated the dose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc9ef65cb971cd785c0e81ce3594d528
https://doi.org/10.14341/dm12790
https://doi.org/10.14341/dm12790